ReviewJournal of experimental & clinical cancer research : CR2022

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity.

Adrià Archilla-Ortega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.